Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6071307 | Journal of the American Academy of Dermatology | 2014 | 23 Pages |
Abstract
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.
Keywords
FDAIFN-gpsoralen plus ultraviolet AAADSCORADTPMTAZAMTXMMFHSVQOLQuality of lifeazathioprineAmerican Academy of Dermatologyoral steroidsUltravioletCSAnarrowbandThiopurine methyltransferaseAtopic dermatitisScoring Atopic DermatitisGastrointestinalFood and Drug AdministrationSystemic therapycyclosporin APhotochemotherapyPhototherapymycophenolate mofetilMethotrexateherpes simplex virusBroadbandPuvaInterferon gamma
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Robert (Co-chair), Dawn M. MD, David E. MD, Kelly M. MD, Timothy G. MD, James N. MD, Sarah L. MD, MSCI, Kevin D. MD, Steven R. MD, PhD, Jon M. MD, Alfons MD, David J. MD, PhD, Amy S. MD, Kathryn MD, Robert A. MD, Eric L. MD, Wynnis L. MD, Hywel C. DSc,